ストックスクリーナーアプリを入手
177.91
0.68%
1.21
プレマーケット:
177.90
-0.010
-0.01%
前日終値:
$176.70
開ける：
$178.13
24時間の取引高:
489.52K
Relative Volume:
0.57
時価総額：
$11.35B
収益：
$13.84B
当期純損益:
$1.10B
株価収益率:
17.08
EPS:
10.4185
ネットキャッシュフロー:
$1.49B
1週間 パフォーマンス:
-0.24%
1か月 パフォーマンス:
-24.92%
6か月 パフォーマンス:
+20.41%
1年 パフォーマンス:
+33.52%
1日の値動き範囲:
$176.90
$179.83
1週間の範囲:
$176.20
$183.57
52週間の値動き範囲:
$101.00
$247.49
Davita Inc Stock (DVA) Company Profile
Compare DVA vs HCA, THC, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
177.91 | 11.27B | 13.84B | 1.10B | 1.49B | 10.42 |
HCA
Hca Healthcare Inc
|
411.73 | 87.68B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
270.21 | 21.30B | 21.46B | 2.65B | 3.35B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
23.56 | 12.51B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
122.10 | 12.03B | 6.07B | 793.80M | 464.40M | 5.9914 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
DaVita (NYSE: DVA) reports new insider stock trade - Stock Titan
DaVita (NYSE: DVA) director Phyllis Yale gets 278-share stock award - Stock Titan
DaVita (NYSE: DVA) insider logs new stock trade in SEC filing - Stock Titan
DaVita (NYSE: DVA) director now holds 5,970 shares after award - Stock Titan
Forever Committed to Excellence in Care: DaVita Community Care Report 2025 - accessnewswire.com
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
DaVita Inc. (DVA) Stock Analysis: A Strong ROE And 21% Potential Upside - DirectorsTalk Interviews
Enterprise value to revenue forward of DaVita Inc. – BX:TRL - TradingView
Stronger Q2 Earnings and Transplant Focus Might Change The Case For Investing In DaVita (DVA) - simplywall.st
Bank of America Corp DE Cuts Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock outperforms competitors despite losses on the day - MarketWatch
DaVita Inc. (DVA) Stock forecasts - Yahoo Finance UK
The Top 5 Analyst Questions From DaVita’s Q2 Earnings Call - Yahoo Finance
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Community Care Report 2025: Creating a Culture of Belonging for All - CSRwire
DaVita Inc. $DVA Shares Sold by Wedge Capital Management L L P NC - MarketBeat
Pacer Advisors Inc. Trims Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc. $DVA Shares Sold by Empowered Funds LLC - MarketBeat
DaVita Inc (DVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Are Wall Street Analysts Bullish on DaVita Stock? - webull.com
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Inc. $DVA Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
DaVita Inc. (DVA) Stock Analysis: Strong Upside Potential with an 18.86% Gain on the Horizon - DirectorsTalk Interviews
9,300 Shares in DaVita Inc. $DVA Purchased by Polianta Ltd - MarketBeat
DaVita (DVA) Stock Still Looks Undervalued Despite A Q2 Earnings Beat - Yahoo Finance
DaVita Inc. (DVA) Stock Forecasts - Yahoo! Finance Canada
Can DaVita’s (DVA) Better Mortality Trends Redefine Its Core Dialysis Investment Story? - webull.com
Why is DaVita stock up 2% today? - Investing.com
DaVita Inc (DVA) Stock News Today - TradingKey
TD Cowen upgrades DaVita stock rating on market position gains - Investing.com
DaVita Shares Rise After TD Cowen Upgrades Stock to Buy - Yahoo Finance
Janus Henderson Group PLC Raises Stock Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc (DVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is DaVita (DVA) a Great Value Stock Right Now? - Yahoo Finance
DaVita Inc. $DVA Shares Bought by California State Teachers Retirement System - MarketBeat
DaVita Inc. (DVA) options chain - Yahoo Finance Australia
SPDR S&P 500(R) Buyback ETF's DaVita Inc(DVA) Holding History - GuruFocus
DaVita Inc (DVA) Shares Fall 17.2% -- GF Value Says Still Overva - GuruFocus
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down - Yahoo Finance
DVA Q2 Deep Dive: Flat Volumes and Policy Transitions Shape Outlook - stockstory.org
DVA Q2 Earnings Call Centers on Clinical-Led Volume Growth - The Globe and Mail
DaVita Inc. $DVA Shares Sold by Amundi - MarketBeat
DaVita Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
DaVita Inc. Stock 12‑Month Price Target Raised to $230, Implies 1% Upside - tradingview.com
Is DaVita Inc (DVA) Overvalued After Q2 Earnings Beat? EPS at $4 - GuruFocus
DaVita Expands Access to Advanced Middle Molecule Clearance - DaVita Newsroom
DaVita Q2 Earnings Call Highlights - TradingView
DaVita Inc (DVA) (Q2 2026) Earnings Call Highlights: Strong Volu - GuruFocus
DaVita's Profit Growth Prospects Boosted by Share Repurchases - Morningstar
Earnings call transcript: DaVita beats Q2 2026 estimates but shares fall - Investing.com
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
0.09%
1.17%
大文字化:
|
ボリューム (24 時間):